Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112687423 | 11268742 | 3 | F | 20150317 | 20160809 | 20150714 | 20160912 | PER | US-JNJFOC-20150705761 | JANSSEN | 62.09 | YR | A | M | Y | 163.30000 | KG | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112687423 | 11268742 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | TABLET | ||||||||
112687423 | 11268742 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 20 | MG | TABLET | ||||||
112687423 | 11268742 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | TABLET | ||||||||
112687423 | 11268742 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 20 | MG | TABLET | ||||||
112687423 | 11268742 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 0 | 20 | MG | TABLET | ||||||
112687423 | 11268742 | 6 | PS | XARELTO | RIVAROXABAN | 1 | Oral | U | U | 202439 | TABLET | ||||||||
112687423 | 11268742 | 7 | SS | IBUPROFEN. | IBUPROFEN | 1 | Unknown | U | U | 17463 | UNSPECIFIED | ||||||||
112687423 | 11268742 | 8 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | Y | 0 | 5 | MG | UNSPECIFIED | |||||||
112687423 | 11268742 | 9 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 12 | C | DIGITEK | DIGOXIN | 1 | 0 | ||||||||||||
112687423 | 11268742 | 13 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 14 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 16 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 17 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
112687423 | 11268742 | 18 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
112687423 | 11268742 | 1 | Atrial fibrillation |
112687423 | 11268742 | 2 | Atrial fibrillation |
112687423 | 11268742 | 3 | Cerebrovascular accident prophylaxis |
112687423 | 11268742 | 4 | Cerebrovascular accident prophylaxis |
112687423 | 11268742 | 5 | Thrombosis prophylaxis |
112687423 | 11268742 | 6 | Thrombosis prophylaxis |
112687423 | 11268742 | 7 | Product used for unknown indication |
112687423 | 11268742 | 8 | Anticoagulant therapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
112687423 | 11268742 | OT |
112687423 | 11268742 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
112687423 | 11268742 | Gastrointestinal haemorrhage | |
112687423 | 11268742 | Internal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
112687423 | 11268742 | 2 | 20150304 | 20150307 | 0 | |
112687423 | 11268742 | 4 | 20150304 | 20150307 | 0 | |
112687423 | 11268742 | 5 | 20150304 | 20150307 | 0 | |
112687423 | 11268742 | 8 | 2011 | 0 |